Navigation Links
Antiseizure Drug Could be Fatal
Date:10/28/2008

Common Sedative Linked to Deaths in Patients With Prolonged Seizures

PHILADELPHIA, Oct. 28 /PRNewswire/ -- Patients treated for their prolonged seizures with the sedative propofol may be at high risk for complications and even death. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), shows that the use of propofol as an antiepileptic agent in patients with refractory status epilepticus (RSE), prolonged seizures that do not respond to initial treatment, was associated with significant mortality and morbidity.

RSE is a difficult clinical problem seen in patients with primary epilepsy and in those with other conditions such as trauma, tumors, and infections affecting the brain. Although propofol is used to treat patients with RSE, it is more commonly used for sedation during surgeries or other patient procedures but at a much lower dose and shorter duration than that used for the control of seizures.

"Patients with RSE treated with propofol are at high risk for propofol-related side effects because of the high propofol infusion rates and prolonged treatment duration necessary in these patients," said Vivek Iyer, MD, Mayo Clinic, Rochester, MN. "However, it is well described that propofol toxicity can occur even with brief exposure to the drug."

Dr. Iyer and his colleagues from Mayo Clinic reviewed 39 consecutive patients (median age of 54 years) from 1997 to 2007, who were admitted to the ICU with RSE, in order to examine the link between propofol use and related side effects, including propofol infusion syndrome (PRIS). PRIS is a usually fatal complication of propofol use that has been reported especially at high infusion rates for prolonged periods. For this study, PRIS was defined by the unexplained presence of at least one or more of the following: metabolic acidosis, rhabdomyolysis, bradycardia, and/or cardiac arrest.

Propofol was used
'/>"/>

SOURCE American College of Chest Physicians
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. HIV denialists spread misinformation online -- consequences could be deadly; and more
4. Virus Could Help Drive Obesity
5. Discovery of sugar sensor in intestine could benefit diabetes
6. Cranberry Could Juice Up Ovarian Cancer Treatment
7. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
8. High-risk behaviors could lead to HIV epidemic in Afghanistan
9. Chinas 1-child policy could backfire on its elderly
10. 1.5 million children could be saved
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... UC San Diego School of Medicine and Osaka University ... prevent liver damage, including inflammation, fibrosis and cancer. The ... protein, TAK1, works could lead to new insights into ... "TAK1 appears to be a master regulator of liver ... and Dean of the UC San Diego School of ...
(Date:12/14/2009)... cites lower rates for meth and smoking, but ... 14 (HealthDay News) -- Fewer teenagers are using ... and abuse of prescription drugs remains high, U.S. ... that newer drugs, such as the hallucinogenic salvia ... intended for treatment of attention-deficit hyperactivity disorder (ADHD), ...
(Date:12/14/2009)... -- Concetta F. Conkling of Moraga, CA, retired Senior ... been elected Chair of the Board of Trustees of ... nearly 90-year-old organization to which Helen Keller devoted more ... York with offices in San Francisco, Dallas, ... dedicated to expanding possibilities for people with vision loss. ...
(Date:12/14/2009)... women,s hospital -- located within the C.S. Mott Children,s ... Jane Von Voigtlander ,, ANN ARBOR, Mich., Dec. ... has received a $15 million gift from the Ted ... made to the Health System for women,s health. It ... ,, The gift is being announced today in advance ...
(Date:12/14/2009)... the December issue of Mayo Clinic Proceedings , ... This retrospective study is the largest ever conducted in ... a serious disorder that disrupts the body,s normal production ... the bone marrow, leading to severe anemia, weakness, fatigue ... "In the past 20 years, management of primary myelofibrosis ...
Breaking Medicine News(10 mins):Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:The American Foundation for the Blind Welcomes New Board Chair, Concetta F. Conkling 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 2Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 3Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 4Health News:University of Michigan Health System Receives $15 Million Gift, The Largest Ever for Women's Health 5
... of Dr. Michael McCarty, is now offering full service ... answer for those who need dental work and yet ... made it safe and comfortable for people to have ... a painful experience. Dr. Michael McCarty from Austin Smiles ...
... at the Stanford University School of ,Medicine have found ... of individual proteins in cells and living mammals, providing ... precisely than ever ,before the functions of different ... speed the development of therapies ,in which cancer-fighting proteins ...
... Over-55 bettors more likely to ask casinos to bar them, ... 28 (HealthDay News) -- Older problem gamblers who ask to ... likely than younger gambling addicts to do so because they,re ... to a new study. , The study included 1,601 ...
... Institutes of Health has awarded iCRco partner Vixar a Phase I SBIR ... images in computed radiography systems. Vixar is developing the new technology ... evaluate the potential of the technology for the digital x-ray imaging market. ... ...
... Sept. 27 Lung Cancer Alliance,President and CEO Laurie ... at Lung Cancer Alliance, our Board, our advocates and ... sympathy,to the wife and family of Paul Newman., ... and film, loved by,audiences around the world. He and ...
... surge in allergy and asthma problems after Hurricane Ike and provides ... ... Houston, TX (PRWEB) September 24, 2008--Although Hurricane Ike has already ... of this devastating hurricane has yet to be determined. It ...
Other Medicine News:Health News:Austin Dentistry Clinic Now Offers Certified Full Service Sedation Dentistry -- All Gain, No Pain 2Health News:New way to control protein activity could lead to cancer therapies 2Health News:New way to control protein activity could lead to cancer therapies 3Health News:Older Problem Gamblers Face Increased Suicide Risk 2Health News:NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco 2Health News:A Statement from Lung Cancer Alliance on the Death of Paul Newman 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 2Health News:Sudden Rise in Allergies and Asthma After Hurricane Ike 3
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
(Date:12/14/2009)... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... to help maintain the bone health of prostate ... therapy (ADT). Nearly two million men are ... that, while highly effective and considered the "gold ... man,s risk for osteoporosis. ,, As part of ...
(Date:12/14/2009)... DOVER, Del., Dec. 14 Ohr Pharmaceutical Inc. ... selected Allen & Caron Inc, headquartered in Irvine, ... London, as its agency for investor relations and ... stage biotechnology company focused on developing advanced drugs ... pipeline compounds with potentially large, global markets: OHR/AVR118 ...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 2Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications 3SPECT provides high quality images of small tumors 48912 1Pregnant women at high risk of complications from H1N1 influenza 48908 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 1Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 2Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 3Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 48904 4
... Israel, February 4 Oramed,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), ... that it has concluded a proof of concept,study ... its,proprietary technology. Eight healthy volunteers came for two ... The insulin suppositories showed rapid insulin absorption ...
... PDUFA Date for Cinryze for Acute HAE Indication is June ... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... priority review for Cinryze C1 Inhibitor (human) as a treatment ... Biologics License Application (sBLA), submitted to the FDA on December ...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: